Clemens Schneeweiss

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.

Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.

Journal: Transfusion medicine (Oxford, England)

Published: May 29, 2026

Therapeutic biologics interference in serological and pre-transfusion testing.

Therapeutic biologics interference in serological and pre-transfusion testing.

Journal: Frontiers in immunology

Published: May 22, 2026

Anti-CD47 drug interference in pre-transfusion testing can be overcome by antigen masking.

Anti-CD47 drug interference in pre-transfusion testing can be overcome by antigen masking.

Journal: Transfusion

Published: April 28, 2025

Antigen masking indirect antiglobulin test can mitigate the interference of Mezagitamab, a novel anti-CD38 antibody, in serological pre-transfusion testing.

Antigen masking indirect antiglobulin test can mitigate the interference of Mezagitamab, a novel anti-CD38 antibody, in serological pre-transfusion testing.

Journal: Transfusion medicine (Oxford, England)

Published: November 14, 2024

KNMB, a novel Knops blood group antigen located in LHR-C.

KNMB, a novel Knops blood group antigen located in LHR-C.

Journal: Transfusion

Published: May 16, 2023

Mitigation of therapeutic anti-CD38 antibody interference with fab fragments: How well does it perform?

Mitigation of therapeutic anti-CD38 antibody interference with fab fragments: How well does it perform?

Journal: Transfusion

Published: July 01, 2022

Two novel antithetical KN blood group antigens may contribute to more than a quarter of all KN antisera in Europe.

Two novel antithetical KN blood group antigens may contribute to more than a quarter of all KN antisera in Europe.

Journal: Transfusion

Published: March 06, 2020

Mechanistic Basis for Epitope Proofreading in the Peptide-Loading Complex.

Mechanistic Basis for Epitope Proofreading in the Peptide-Loading Complex.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: July 29, 2015

Recombinant blood group proteins facilitate the detection of alloantibodies to high-prevalence antigens and reveal underlying antibodies: results of an international study.

Recombinant blood group proteins facilitate the detection of alloantibodies to high-prevalence antigens and reveal underlying antibodies: results of an international study.

Journal: Transfusion

Published: September 30, 2013

Showing 1-9 of 9

Last Updated: 09/26/2026